| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10157743 | Pathology - Research and Practice | 2018 | 6 Pages |
Abstract
A simultaneous next-generation targeted DNA and RNA sequencing is applicable on routine formalin-fixed paraffin-embedded tissues to assess the multigene molecular asset of individual prostate cancers. This approach, coupled with immunohistochemistry for ERG and mTOR pathway proteins, may help to better characterize prostate cancer molecular features with a potential impact on clinical decisions.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Caterina Vicentini, Cinzia Cantù, Davide Antonello, Michele Simbolo, Andrea Mafficini, Claudio Luchini, Borislav Rusev, Antonio Benito Porcaro, Roberto Lacovelli, Matteo Fassan, Vincenzo Corbo, Matteo Brunelli, Walter Artibani, Aldo Scarpa,